Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report.
Saved in:
| Title: | Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report. |
|---|---|
| Authors: | Tsukasa Y; Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN., Sugimoto Y; Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN., Yamamoto T; Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN., Aoki R; Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN., Nakano H; Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN. |
| Source: | Cureus [Cureus] 2026 Apr 28; Vol. 18 (4), pp. e107914. Date of Electronic Publication: 2026 Apr 28 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2168-8184 |
|---|---|
| DOI: | 10.7759/cureus.107914 |
